A NIGHT OF INNOVATION AT THE PAN PACIFIC LONDON: ENHANCING DIAGNOSTIC PRECISION & TRANSFORMING PROSTATE CANCER CARE: ARTERA AI AND AI-POWERED BIOMARKER INNOVATION
This event, hosted by Diagnexia in collaboration with Artera, focuses on how AI-powered biomarkers are transforming prostate cancer diagnosis and treatment. Experts in urology, histopathology, and digital innovation will explore the role of the ArteraAI Prostate Biopsy Assay, which enhances risk stratification and informs clinical decision-making, ultimately improving patient outcomes.
Download as vCalendar (for Microsoft Outlook etc.)
Import event to your Google Calendar
FEATURED SESSIONS AND SPEAKERS:
WELCOME ADDRESS & INTRODUCTION TO DIAGNEXIA
Donal O’Shea, Chief Executive Officer at Diagnexia
Professor Runjan Chetty, Chief Medical Officer at Diagnexia
AI IN FOCUS: REVOLUTIONISING PROSTATE CANCER CARE WITH ARTERA AI
Dr. Pedro Soares de Oliveira, Consultant Histopathologist at The Christie NHS Foundation Trust
ADVANCING DIGITAL PATHOLOGY IN THE UK: ARTERAAI'S NOVEL APPROACH TO PROSTATE CANCER RISK STRATIFICATION
Zach Wilczynski, MS, Director of Product Management at ArteraAI
TITLE TBC
Professor Noel Clarke, Consultant Urologist at Salford Royal Hospital and The Christie NHS Trust
Presentations yet to be made.
Website: https://www.diagnexia.com
Event contact details
Charli-Ann Lynch Email: charli-ann.lynch@diagnexia.com Telephone: +353 404 33389 Event website